Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients-Reference-Cited by-同舟云学术

Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients

Published:2024-02-06 Issue:4 Volume:44 Page:675-685
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Wilk Mateusz^ORCID,Michelsen Brigitte^ORCID,Łosińska Katarzyna^ORCID,Kavanaugh Arthur^ORCID,Korkosz Mariusz^ORCID,Haugeberg Glenn^ORCID

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00296-024-05536-1.pdf

Reference43 articles.

1. Hoff M, Gulati AM, Romundstad PR et al (2015) Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag health study (HUNT). Ann Rheum Dis 74:60–64. https://doi.org/10.1136/ANNRHEUMDIS-2013-203862

2. Kerola AM, Rollefstad S, Kazemi A et al (2023) Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol 52:42–50. https://doi.org/10.1080/03009742.2021.1997436

3. Campanholo CB, Maharaj AB, Corp N et al (2022) Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol jrheum. https://doi.org/10.3899/JRHEUM.220310

4. Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharmacy and Therapeutics 35:680

5. Gottlieb A, Gratacos J, Dikranian A et al (2019) Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe. Rheumatol Int 39:121–130. https://doi.org/10.1007/S00296-018-4195-X/TABLES/2